Laurus Labs Q1 Profit Soars 1144%

  Published 1 year ago

Laurus Labs posted strong Q1 FY26 growth, driven by CDMO surge, margin gains, and strategic expansion in Andhra Pradesh.

  • CDMO revenue doubled YoY to Rs 522 crore, while FDF rose 50%, supporting robust business performance.
  • EBITDA jumped 127% to Rs 389 crore; margins expanded due to operating leverage and better CDMO product mix.
  • Andhra Pradesh allotted 531.77 acres for Rs 5,630 crore Laurus Pharma Zone, expected to create 6,350 jobs.

You might like these

Nuvoco Vistas Tax Demand: ₹65.5M

BluSmart Faces Insolvency Trouble

Tata Motors Sales & Profit Update, May 2025

RailTel to Install 8 AI Billboards in Cuttack by 2025

Markets Dip on Global Tariff Woes

JSW Steel FY25: Mixed Results & Outlook

BRICS Trade Talks Focus on South, South Cooperation

News that matters the most ⚡